KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Income Before Tax

Profit after all operating and non-operating items but before income tax.

KORU Medical Systems, Inc.NASDAQ: KRMD

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$807.08K, compared with -$1.17M a year earlier. Trailing-twelve-month income before tax was -$2.26M.

Context

  • Income before tax amounted to 6.4% of revenue in FY2025, down 11.7 pp from a year earlier.
  • Income before tax grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income before tax holds near -$807.08K or moves back toward the trailing-twelve-month quarterly average of -$564.22K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$807.08K-67.4% QoQ
Last fiscal yearDec 2025
-$2.62M+56.9% YoY
LTMMar 2026
-$2.26M+57.4% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+30.8%——
1 year+56.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(2.62M) USD
Year-over-year change
+56.9%

Income Before Tax vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +57.4% is the 2nd highest of 10, against a peer median of -2.6%.
  • Income before tax amounts to 5.2% of revenue for KRMD, versus a peer median of 64.5%.
KRMD Competitors
Income Before Tax for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UTMDUtah Medical Products, Inc.LTM Mar 2026$13.43M USD-15.3%-11.9%35.8%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$11.79M USD+78.3%+333.9%8.3%
KRMDKORU Medical Systems, Inc.LTM Mar 2026-$2.26M USD+57.4%—5.2%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-$27.31M USD-0.4%—60.8%
STIMNeuronetics, Inc.LTM Mar 2026-$37.25M USD+23.3%—24.6%
PROFProfound Medical Corp.LTM Mar 2026-$38.96M USD-2.6%—206.5%
MXCTMaxCyte, Inc.LTM Mar 2026-$39.12M USD+6.4%—121.2%
OSUROraSure Technologies, Inc.LTM Mar 2026-$73.24M USD-139.4%—64.8%
PREPrenetics Global LimitedLTM Mar 2026-$73.41M USD-23.8%—64.5%
NYXHNyxoah S.A.LTM Mar 2026-€84.79M EUR-26.7%—519.6%
Peer median (excluding KRMD) —-2.6%+161.0%64.5%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.